TLR2 and HIV infectious disease: Compared to the single docking analysis of Choudhury et al. [33], which only focused on TLR2, the present study demonstrated that the vaccine strongly interacted with both TLR2/3/4, covering the critical TLR3 pathway in HIV infection, which is more relevant to the needs of immune activation in co-infections.